ISCTM 10th Anniversary Annual Scientific Meeting

The International Society for CNS Clinical Trials and Methodology (ISCTM) is a multi-disciplinary independent organization, devoted to promoting advances that address strategic clinical, regulatory, methodological and policy challenges that arise in the development and use of CNS therapeutic agents.  This work is accomplished through partnership with persons in academia, industry, government, policy-making, and the public.

Сайт общества: http://isctm.org/

ISCTM 10th Anniversary Annual Scientific Meeting
 

18-20 February 2014
The Fairmont, Washington DC

PRELIMINARY AGENDA

Day 1 - Tuesday 18 February 2014

Developing Treatments for Schizophrenia in the 21st Century:  Preventing Disease Progression—
A New Paradigm for Research
Chairs: Ravi Anand, MD; George Haig, PharmD

Working Group Dinners

Day 2 - Wednesday 19 February 2014

Mental Health Policy Forum: Revitalizing Academia-Industry Collaboration in Psychiatry Treatment Research
Chairs: Reuven Ferziger, MD; Ron Manderscheid, PhD

Dementia: Study Designs, Methodologies and Regulatory Perspectives – One size does not fit all!
Chairs: Jill Rasmussen,MD;  Pierre Tariot, MD

Taking Personalized Medicine Seriously – Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia
Chairs: Thomas Laughren, MD; Harald Murck, MD

Poster Session/Reception

Day 3 - Thursday 20 February 2014

Opportunities and Challenges Using Novel Platforms; Patient Networks and Clinical Databases 
Chairs: Joanne Severe, MS;  Robert Heinssen, PhD, ABPP

DSM5 / RDoC:  Implications for CNS Trial Design
Chairs: TBD

психофармакотерапия (81) ISCTM (1)